Rook Khajenouri
About Rook Khajenouri
Rook Khajenouri serves as the Director of Sales for Antibody Services at Inotiv, where he has worked since 2021. With extensive experience in the field, he has held various sales management roles, including a long tenure at Harlan Bioproducts and Envigo, and possesses expertise in monoclonal antibody production and purification.
Current Role at Inotiv
Rook Khajenouri currently serves as the Director of Sales for Antibody Services at Inotiv, a position he has held since 2021. In this role, he is responsible for overseeing the sales operations related to antibody services, which include monoclonal and polyclonal antibody production. His work focuses on meeting the needs of clients in the biopharmaceutical sector, ensuring that they receive high-quality products and services tailored to their research requirements.
Previous Experience at Harlan Bioproducts
Prior to his current role, Rook Khajenouri worked at Harlan Bioproducts for Science, Inc. as the Manager of Sales from 1988 to 2014. During his 26 years with the company, he developed extensive knowledge in the sales of biological products and services. His long tenure allowed him to build strong relationships within the industry and gain insights into the evolving needs of clients in the life sciences sector.
Experience at Envigo
Rook Khajenouri served as the Director of Sales for Antibody Services at Envigo from 2014 to 2021. In this role, he managed the sales team and was instrumental in promoting antibody services, including monoclonal antibody production and purification. His leadership contributed to the growth of the sales division and enhanced the company's reputation in the antibody services market.
Education and Expertise
Rook Khajenouri studied at Indiana University–Purdue University Indianapolis from 1980 to 1984, where he gained foundational knowledge that supports his career in sales and bioproducts. He possesses expertise in monoclonal antibody production and purification under current Good Manufacturing Practices (cGMP) and research guidelines. His technical knowledge enables him to effectively communicate with clients about complex biological products, including growth factors and hybridoma development.
Services Offered
In his current role and previous positions, Rook Khajenouri has been involved in offering a range of additional services related to antibody production. These services include purification, conjugation, and fragmentation of antibodies. He oversees the production of polyclonal antibodies and the development of hybridomas, ensuring that clients receive comprehensive solutions tailored to their research and development needs.